230 related articles for article (PubMed ID: 28378518)
21. Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy.
Nolli C; Goffrini P; Lazzaretti M; Zanna C; Vitale R; Lodi T; Baruffini E
Mitochondrion; 2015 Nov; 25():38-48. PubMed ID: 26455272
[TBL] [Abstract][Full Text] [Related]
22. Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy.
Ahuja AS; Selvam P; Vadlamudi C; Chopra H; Richter JE; Macklin SK; Samreen A; Helmi H; Mohammaad AN; Hines S; Davila MC; Atwal PS; Caulfield TR
Ophthalmic Genet; 2020 Dec; 41(6):563-569. PubMed ID: 32940104
[TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families.
Pretegiani E; Rosini F; Rufa A; Gallus GN; Cardaioli E; Da Pozzo P; Bianchi S; Serchi V; Collura M; Franceschini R; Bianchi Marzoli S; Dotti MT; Federico A
J Neurol Sci; 2017 Nov; 382():29-35. PubMed ID: 29111013
[TBL] [Abstract][Full Text] [Related]
24. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.
Olichon A; Landes T; Arnauné-Pelloquin L; Emorine LJ; Mils V; Guichet A; Delettre C; Hamel C; Amati-Bonneau P; Bonneau D; Reynier P; Lenaers G; Belenguer P
J Cell Physiol; 2007 May; 211(2):423-30. PubMed ID: 17167772
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
[TBL] [Abstract][Full Text] [Related]
26. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.
Amati-Bonneau P; Valentino ML; Reynier P; Gallardo ME; Bornstein B; Boissière A; Campos Y; Rivera H; de la Aleja JG; Carroccia R; Iommarini L; Labauge P; Figarella-Branger D; Marcorelles P; Furby A; Beauvais K; Letournel F; Liguori R; La Morgia C; Montagna P; Liguori M; Zanna C; Rugolo M; Cossarizza A; Wissinger B; Verny C; Schwarzenbacher R; Martín MA; Arenas J; Ayuso C; Garesse R; Lenaers G; Bonneau D; Carelli V
Brain; 2008 Feb; 131(Pt 2):338-51. PubMed ID: 18158317
[TBL] [Abstract][Full Text] [Related]
27. OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy.
Han J; Thompson-Lowrey AJ; Reiss A; Mayorov V; Jia H; Biousse V; Newman NJ; Brown MD
Genet Med; 2006 Apr; 8(4):217-25. PubMed ID: 16617242
[TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant optic atrophy with
Maeda-Katahira A; Nakamura N; Hayashi T; Katagiri S; Shimizu S; Ohde H; Matsunaga T; Kaga K; Nakano T; Kameya S; Matsuura T; Fujinami K; Iwata T; Tsunoda K
Mol Vis; 2019; 25():559-573. PubMed ID: 31673222
[TBL] [Abstract][Full Text] [Related]
29. Changes in Mitochondrial Morphology and Bioenergetics in Human Lymphoblastoid Cells With Four Novel OPA1 Mutations.
Kao SH; Yen MY; Wang AG; Yeh YL; Lin AL
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2269-78. PubMed ID: 25744979
[TBL] [Abstract][Full Text] [Related]
30. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
[TBL] [Abstract][Full Text] [Related]
31. Novel mutations of the OPA1 gene in Chinese dominant optic atrophy.
Yen MY; Wang AG; Lin YC; Fann MJ; Hsiao KJ
Ophthalmology; 2010 Feb; 117(2):392-6.e1. PubMed ID: 19969356
[TBL] [Abstract][Full Text] [Related]
32. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.
Payne M; Yang Z; Katz BJ; Warner JE; Weight CJ; Zhao Y; Pearson ED; Treft RL; Hillman T; Kennedy RJ; Meire FM; Zhang K
Am J Ophthalmol; 2004 Nov; 138(5):749-55. PubMed ID: 15531309
[TBL] [Abstract][Full Text] [Related]
33. Molecular Impairment Mechanisms of Novel OPA1 Mutations Predicted by Molecular Modeling in Patients With Autosomal Dominant Optic Atrophy and Auditory Neuropathy Spectrum Disorder.
Namba K; Mutai H; Takiguchi Y; Yagi H; Okuyama T; Oba S; Yamagishi R; Kaneko H; Shintani T; Kaga K; Matsunaga T
Otol Neurotol; 2016 Apr; 37(4):394-402. PubMed ID: 26905822
[TBL] [Abstract][Full Text] [Related]
34. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.
Lodi R; Tonon C; Valentino ML; Iotti S; Clementi V; Malucelli E; Barboni P; Longanesi L; Schimpf S; Wissinger B; Baruzzi A; Barbiroli B; Carelli V
Ann Neurol; 2004 Nov; 56(5):719-23. PubMed ID: 15505825
[TBL] [Abstract][Full Text] [Related]
35. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.
Davies VJ; Hollins AJ; Piechota MJ; Yip W; Davies JR; White KE; Nicols PP; Boulton ME; Votruba M
Hum Mol Genet; 2007 Jun; 16(11):1307-18. PubMed ID: 17428816
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy.
Mayorov VI; Lowrey AJ; Biousse V; Newman NJ; Cline SD; Brown MD
BMC Biochem; 2008 Sep; 9():22. PubMed ID: 18783614
[TBL] [Abstract][Full Text] [Related]
37. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations.
Yu-Wai-Man P; Bailie M; Atawan A; Chinnery PF; Griffiths PG
Eye (Lond); 2011 May; 25(5):596-602. PubMed ID: 21378995
[TBL] [Abstract][Full Text] [Related]
38. Pathogenicity evaluation and the genotype-phenotype analysis of OPA1 variants.
Xu X; Wang P; Jia X; Sun W; Li S; Xiao X; Hejtmancik JF; Zhang Q
Mol Genet Genomics; 2021 Jul; 296(4):845-862. PubMed ID: 33884488
[TBL] [Abstract][Full Text] [Related]
39. OPA1 analysis in an international series of probands with bilateral optic atrophy.
Liskova P; Tesarova M; Dudakova L; Svecova S; Kolarova H; Honzik T; Seto S; Votruba M
Acta Ophthalmol; 2017 Jun; 95(4):363-369. PubMed ID: 27860320
[TBL] [Abstract][Full Text] [Related]
40. Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation.
Chun BY; Rizzo JF
Curr Opin Ophthalmol; 2016 Nov; 27(6):475-480. PubMed ID: 27585216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
